Discover how PathoQuest enables new biotherapies to be delivered rapidly and safely to patients with its quality testing platform in this episode of the AWS Health Innovation Podcast. PathoQuest’s CEO, Jean-François shares details about Pathoquest’s groundbreaking, GMP certified, next-generation sequencing (NGS) approach to genetic characterization and viral testing. Also learn about the company’s international expansion from Europe to the U.S.

Serving global biopharmaceutical companies and emerging biotechs, Pathoquest provides a robust QC solution to accelerate the manufacturing of biologics.

CLICK HERE to listen to the Podcast